ConductScience.org, home

Paper32437331

Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.

Shrestha B and 14 others. J Clin Invest, 2020. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease. Papers, record 32437331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32437331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
PubMed
Journal
J Clin Invest
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Video-Audio Media
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2026-01-27
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shrestha BBishwas
2Walton KKelly
3Reff JJordan
4Sagatys EMElizabeth M
5Tu NNhan
6Boucher JJustin
7Li GGongbo
8Ghafoor TTayyebb
9Felices MMartin
10Miller JSJeffrey S
11Pidala JJoseph
12Blazar BRBruce R
13Anasetti CClaudio
14Betts BCBrian C
15Davila MLMarco L

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adoptive TransferMajor topic
Antigens, CDMajor topic
CD4-Positive T-LymphocytesMajor topic
Graft vs Host DiseaseMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
ImmunoglobulinsMajor topic
Leukemia, Myeloid, AcuteMajor topic
Membrane GlycoproteinsMajor topic
Neoplasm ProteinsMajor topic
Receptors, Chimeric AntigenMajor topic
Allografts
Animals
Cell Line, Tumor
Humans
Mice
CD83 Antigen

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL133823NHLBI NIH HHSUnited StatesR01HL133823PubMed and NIHNIH RePORTER
P30 CA077598NCI NIH HHSUnited StatesP30CA077598PubMed and NIHNIH RePORTER
R01 HL118979NHLBI NIH HHSUnited StatesR01HL118979PubMed and NIHNIH RePORTER
R01 HL126530NHLBI NIH HHSUnited StatesR01HL126530PubMedNIH RePORTER
R01 HL147324NHLBI NIH HHSUnited StatesR01HL147324PubMedNIH RePORTER
R37 AI034495NIAID NIH HHSUnited StatesR37AI034495PubMed and NIHNIH RePORTER
P30 CA076292NCI NIH HHSUnited StatesP30CA076292PubMed and NIHNIH RePORTER
R01 HL155114NHLBI NIH HHSUnited StatesR01HL155114PubMedNIH RePORTER
R01 HL056067NHLBI NIH HHSUnited StatesR01HL056067PubMed and NIHNIH RePORTER
K08 HL116547NHLBI NIH HHSUnited StatesK08HL116547PubMed and NIHNIH RePORTER
P01 CA142106NCI NIH HHSUnited StatesP01CA142106PubMedNIH RePORTER
K12 CA090625NCI NIH HHSUnited StatesK12CA090625PubMedNIH RePORTER
P01 CA065493NCI NIH HHSUnited StatesP01CA065493PubMed and NIHNIH RePORTER

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130574153Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.Front Immunol2018https://conductscience.org/library/papers/30574153PubMed
211748282The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.J Exp Med2001https://conductscience.org/library/papers/11748282PubMed
311896281Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.Science2002https://conductscience.org/library/papers/11896281PubMed
428416503Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.Blood2017https://conductscience.org/library/papers/28416503PubMed
582837Cyclosporin A for the treatment of graft-versus-host disease in man.Lancet1978https://conductscience.org/library/papers/82837PubMed
619804837T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19804837PubMed
729385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
828067900Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.Nat Med2017https://conductscience.org/library/papers/28067900PubMed
920952687Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Blood2011https://conductscience.org/library/papers/20952687PubMed
1020807889Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.Blood2010https://conductscience.org/library/papers/20807889PubMed
1131811055T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.Sci Immunol2019https://conductscience.org/library/papers/31811055PubMed
1224553386Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.Sci Transl Med2014https://conductscience.org/library/papers/24553386PubMed
1323851696Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival.J Immunol2013https://conductscience.org/library/papers/23851696PubMed
1429875316CD83 expression is essential for Treg cell differentiation and stability.JCI Insight2018https://conductscience.org/library/papers/29875316PubMed
1529382747Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29382747PubMed
1630479692
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.
Oncotarget2018https://conductscience.org/library/papers/30479692PubMed
1723908471Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.Blood2013https://conductscience.org/library/papers/23908471PubMed
1824982504Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.Blood2014https://conductscience.org/library/papers/24982504PubMed
1928375154Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.J Clin Invest2017https://conductscience.org/library/papers/28375154PubMed
2026563133Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.Blood2016https://conductscience.org/library/papers/26563133PubMed

See all 58 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42933888CD83 CAR T provides an alternative strategy to CD19-targeting in B cell malignancies.J Immunother Cancer2026https://conductscience.org/library/papers/42933888PubMed
42755912Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.Front Immunol2026https://conductscience.org/library/papers/42755912PubMed
42575882CAR T cell therapy beyond cancer: current status, challenges and future prospects.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42575882PubMed
42159047Current Status of Treg Therapy in Transplantation and Autoimmune Disease.Immunology2026https://conductscience.org/library/papers/42159047PubMed
42084784Advances in Cell Therapy for Chronic Graft-versus-Host Disease: Prophylactic and Therapeutic Perspectives.Clin Exp Med2026https://conductscience.org/library/papers/42084784PubMed
41721623Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity.Cancer Res Commun2026https://conductscience.org/library/papers/41721623PubMed
41172558Regulatory T cell approaches for graft-versus-host disease prevention.Curr Opin Immunol2026https://conductscience.org/library/papers/41172558PubMed
40206475Cell therapies for immune-mediated disorders.Front Med (Lausanne)2025https://conductscience.org/library/papers/40206475PubMed
40117296Cellular therapies for the prevention and treatment of acute graft-versus-host disease.Stem Cells2025https://conductscience.org/library/papers/40117296PubMed
40117019Tonic signaling in CAR-T therapy: the lever long enough to move the planet.Front Med2025https://conductscience.org/library/papers/40117019PubMed
39915926Chronic Graft-versus-host Disease, Part 2: Clinical Success and Roadmap to the Future.Transplantation2025https://conductscience.org/library/papers/39915926PubMed
39451198Mini-Review: Tregs as a Tool for Therapy-Obvious and Non-Obvious Challenges and Solutions.Cells2024https://conductscience.org/library/papers/39451198PubMed
39242117Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models.J Immunother Cancer2024https://conductscience.org/library/papers/39242117PubMed
39113144Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism.J Transl Med2024https://conductscience.org/library/papers/39113144PubMed
38986621Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.Cell Rep Med2024https://conductscience.org/library/papers/38986621PubMed
38702309Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression.Nat Commun2024https://conductscience.org/library/papers/38702309PubMed
38659486Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives.World J Gastroenterol2024https://conductscience.org/library/papers/38659486PubMed
38618950Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation.J Clin Invest2024https://conductscience.org/library/papers/38618950PubMed
38283344Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation.Front Immunol2023https://conductscience.org/library/papers/38283344PubMed
37958378Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape.Cancers (Basel)2023https://conductscience.org/library/papers/37958378PubMed

See all 36 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD839308PubTator's text mininghttps://conductscience.org/library/genes/9308NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32437331

GET https://conductscience.org/api/papers/v1/32437331/references?page=2